Citation APA
Modi, S., Jacot, W., Yamashita, T., Sohn, J., Vidal, M. J. M., Tokunaga, E., Tsurutani, J., Ueno, N. T., Prat, A., Chae, Y. S., Lee, K. S., Niikura, N., Park, Y. H., Xu, B., Wang, X., Gil-Gil, M., Li, W., Pierga, J. Y. V. J., Im, S. –., Moore, H. C. F., Rugo, H. H., Yerushalmi, R., Zagouri, F., Gombos, A., Kim, S.-B., Liu, Q., Luo, T., Saura, C., Schmid, P., Sun, T., Gambhire, D., Yung, L., Wang, Y., Singh, J., Vitazka, P., Meinhardt, G., Harbeck, N., & Cameron, D. A. (2022). Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. The New England journal of medicine, 387(1), 9-20. doi:10.1056/NEJMoa2203690
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/346888